EBS vs EIX
Emergent Biosolutions Inc (EBS) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
EBS currently screens at market cap $416.4M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the EBS and EIX stock pages for the full models.
Not investment advice.